Nanobiotix (NBTX) Stock Price, Quote, News & History | Benzinga

Nanobiotix SA (NBTX) Stock Price, Quote, News & History

NBTXNASDAQ

Trade with Public

Trade with Public

$41.23

-3.93-8.7%

At close: Aug 28, 5:00 PM EST

$45.50

4.2710.36%

After Hours: Aug 27, 4:10 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

$44.55

Close

$41.23

Volume / Avg.

164.86K / 119.79K

Day Range

$40.49 - $45.03

52 Wk Range

8.03 - 57.14

Market Cap

$2.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.36%

Days to Cover

1

Recent Nanobiotix SA News

XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-expected earnings and naming new CFO. Other stocks also trading lower.

Avi Kapoor

Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market trading include AMST, HAO, MTVA, ONCO, SDA, PIII, VRAX, PURR, BKKT, WOK, BTM, and UBXG.

Avi Kapoor

Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.

Avi Kapoor

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix rejects takeover talk after J&J speculation; stock jumps as analysts weigh momentum strength against mixed technical signals.

Vandana Singh

El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday

U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-expected Q4 results and Benchmark upgrade.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-33.42M

Investing Cash Flow (TTM)

-578.00K

Financing Cash Flow (TTM)

37.42M

Free Cash Flow (TTM)

-33.97M

Capital Expenditure (TTM)

-546.00K

Net Change in Cash (TTM)

3.42M

Analyst Trends and Forecast

1

Apr

1

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.20B

PE Ratio (TTM)

-

PE Ratio (FWD)

121.95

PEG Ratio (TTM)

-

PS Ratio (TTM)

62.67

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-1.29%

Earnings Yield % (FWD)

0.82%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.94

Company Debt

Total Debt

$92.22M

LT Debt

$89.12M

LT Debt Issuance (TTM)

$42.93M

LT Debt Repayment (TTM)

-$4.74M

Total Cash

$52.75M

Debt to Equity

-

Issuance of Debt (TTM)

$38.19M

Repayment of Debt (TTM)

-$4.74M

Key Statistics

Open

$44.55

Close

$41.23

Volume / Avg.

164.86K / 119.79K

Day Range

$40.49 - $45.03

52 Wk Range

8.03 - 57.14

Market Cap

$2.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.36%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and exp...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Nanobiotix (NBTX) stock?

A

You can purchase shares of Nanobiotix (NASDAQ:NBTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nanobiotix (NBTX) competitors?

A

Other companies in Nanobiotix’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Nanobiotix (NBTX) stock?

A

Nanobiotix has a consensus price target of $37.33.

Q

What is the current price for Nanobiotix (NBTX)?

A

The stock price for Nanobiotix (NASDAQ: NBTX) is $45.5 last updated August 27, 2026 at 4:10 PM EDT.

Q

Does Nanobiotix (NBTX) pay a dividend?

A

There are no upcoming dividends for Nanobiotix.

Q

When is Nanobiotix (NASDAQ:NBTX) reporting earnings?

A

Nanobiotix does not have any upcoming earnings scheduled.

Q

Is Nanobiotix (NBTX) going to split?

A

There is no upcoming split for Nanobiotix.

Q

What sector and industry does Nanobiotix (NBTX) operate in?

A

Nanobiotix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.